HAPLN1 and cancer: HAPLN1 was second highest expressed gene in LECs and as tumors take the advantage of these metastatic potential enhancing molecules, the observed high HAPLN1 expression can lead to new therapeutic treatments for metastasis of cancer to lymph nodes.